Iron Triangle Partners LP
- SEC CIK
- 0001779763
- Latest filing
- Feb 17, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 27
- +5 vs. Q4 2024
- Portfolio value
- $634.4M
- −$223.5M (−26.1%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | CL A COM | 1,000,000 | $8.73M | 1.4% | +1,000,000 | New | History |
| EHABEnhabit, Inc. | COM | 1,140,000 | $10.0M | 1.6% | +1,140,000 | New | History |
| BTSGBrightSpring Health Services, Inc. | COM | 722,341 | $13.1M | 2.1% | +722,341 | New | History |
| TECHBIO-TECHNE Corp | COM | 250,000 | $14.7M | 2.3% | +250,000 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 30,000 | $14.9M | 2.3% | −45,000−60.0% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 2,134,061 | $15.9M | 2.5% | +2,134,061 | New | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 130,000 | $16.1M | 2.5% | +130,000 | New | History |
| NBIXNeurocrine Biosciences Inc | Stock | 146,836 | $16.2M | 2.6% | −171,359−53.9% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 27,874 | $16.5M | 2.6% | −7,126−20.4% | Reduced | History |
| TWSTTwist Bioscience Corp | COM | 423,913 | $16.6M | 2.6% | −68,558−13.9% | Reduced | History |
| AHCOAdaptHealth Corp. | COMMON STOCK | 1,614,045 | $17.5M | 2.8% | +1,614,045 | New | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 65,409 | $17.7M | 2.8% | +65,409 | New | History |
| DOCSDoximity, Inc. | CL A | 360,000 | $20.9M | 3.3% | +47,425+15.2% | Added | History |
| NVSTEnvista Holdings Corp | COM | 1,232,798 | $21.3M | 3.4% | −967,202−44.0% | Reduced | History |
| MMSIMerit Medical Systems Inc | COM | 229,738 | $24.3M | 3.8% | −177,284−43.6% | Reduced | History |
| AAgilent Technologies, Inc. | COM | 208,438 | $24.4M | 3.8% | −387,888−65.0% | Reduced | History |
| GHGuardant Health, Inc. | COM | 600,867 | $25.6M | 4.0% | +600,867 | New | History |
| ONCBeOne Medicines Ltd. | ADR | 97,840 | $26.6M | 4.2% | +97,840 | New | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 376,330 | $27.7M | 4.4% | +376,330 | New | History |
| PODDInsulet Corp | Stock | 106,029 | $27.8M | 4.4% | −47,985−31.2% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 209,454 | $28.2M | 4.4% | +209,454 | New | History |
| GMEDGlobus Medical Inc | Stock | 431,221 | $31.6M | 5.0% | −412,792−48.9% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 332,167 | $33.5M | 5.3% | −162,842−32.9% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,217,730 | $34.1M | 5.4% | +17,694+0.8% | Added | History |
| ABBVAbbVie Inc. | Stock | 192,819 | $40.4M | 6.4% | −181,193−48.4% | Reduced | History |
| CAHCardinal Health Inc | Stock | 300,000 | $41.3M | 6.5% | +113,998+61.3% | Added | History |
| DVADavita Inc. | COM | 319,566 | $48.9M | 7.7% | +59,142+22.7% | Added | History |
Sold out since Q4 2024 (7)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| UNHUnitedHealth Group Inc | Stock | 120,700 | $61.1M | 7.1% | History |
| EXASExact Sciences Corp | COM | 600,000 | $33.7M | 3.9% | History |
| HQYHealthequity, Inc. | COM | 335,614 | $32.2M | 3.8% | History |
| MEDPMedpace Holdings, Inc. | COM | 90,000 | $29.9M | 3.5% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 250,000 | $22.5M | 2.6% | – |
| GKOSGLAUKOS Corp | COM | 150,000 | $22.5M | 2.6% | History |
| WAYWaystar Holding Corp. | COM | 551,893 | $20.3M | 2.4% | History |